Dr Jim McAlpine, Vice-President, Chemistry and Discovery, today made a presentation about the ability of the DECIPHER® platform to discover New Chemical Entities (NCE) from bacteria. The DECIPHER® technology is Ecopia's unique drug discovery platform from which more than 59 NCEs were discovered including ECO-4601; the company's lead anticancer product now in Phase I clinical trial.
